TABLE 3.
Previous ATTRv prevalence estimations.
| Country | Disease classification | Prevalence | Method | Published year | References |
|---|---|---|---|---|---|
| Northern Sweden | ATTR-FAP | 104/100,000 | Traditional methods | 1976 | Andersson (1976) |
| Japan | ATTRv | 15/100,000 | Traditional methods | 2002 | Ikeda et al. (2002) |
| Japan | ATTRv | 1.1/100,000 | Traditional methods | 2008 | Kato-Motozaki et al. (2008) |
| Cyprus | ATTR-FAP | 3.72/100,000 | Traditional methods | 2009 | Dardiotis et al. (2009) |
| Northern Portugal | ATTR-FAP | 151/100,000 | Traditional methods | 1995 | Sousa et al. (1995) |
| Austria | ATTRv | 0.5/100,000 | Traditional methods | 2019 | Auer-Grumbach et al. (2020) |
| Italy | ATTRv | 0.433/100,000 | Traditional methods | 2020 | Russo et al. (2020) |
| Saudi | ATTRv | 21.5/100,000 | Genome database | 2021 | Abouelhoda et al. (2021) |
| Worldwide | ATTR-FAP | 10186-38,468 individuals | Traditional methods | 2017 | Schmidt et al. (2018) |
| Worldwide | ATTRv | 57.4/100,000 | Genome database | — | Present study |
| China | ATTRv | 18.9–74.9/100,000 | Genome database | — | Present study |
ATTRv, transthyretin amyloidosis; ATTR-FAP, transthyretin familial amyloid polyneuropathy; Traditional methods refers to case reports, epidemiological surveys, and patient registries.